What do “US8158616B2” and “Example 62/63/69/70” refer to?
US8158616B2 is a US patent publication identified by its patent number. The references to “Example 62, Example 63, Example 69, and Example 70” typically point to specific worked examples inside that patent’s specification (for example, particular formulations, compounds, experimental procedures, or test results described in those example sections). To connect those examples to baricitinib, you would need the exact text of those example entries or at least the chemical/technical context they describe.
With only the patent number and the example numbers provided, there is not enough information to state what each example contains or whether it is directly about baricitinib.
Is baricitinib mentioned in US8158616B2? How can you check?
A reliable way to verify whether baricitinib appears in US8158616B2 is to search within the patent document text for:
- “baricitinib” and common spellings/variants
- IUPAC names or code names used in the patent
- structural descriptors tied to JAK inhibitors (if the patent is about JAK inhibitors)
- related salts/formulations if baricitinib is discussed indirectly (for example, as a component in a composition)
If you paste the relevant excerpt from Examples 62/63/69/70 (or the parts of the patent where baricitinib is discussed), I can map the example content to baricitinib much more precisely.
Are those examples likely about baricitinib specifically or about a broader chemical class?
Many patents around kinase/JAK inhibitor chemistry describe a family of related compounds. In such cases, individual “Examples” can describe:
- synthesis routes for a range of candidate molecules,
- characterization data (NMR, MS),
- biological assay results for different candidates, or
- formulation details.
If US8158616B2 is a chemistry or pharmaceutical composition patent rather than a baricitinib-only patent, Examples 62/63/69/70 could be about related analogs that are not baricitinib itself, even if they are in the same general therapeutic class.
What do people usually want when they search this kind of query?
Queries like “US8158616B2 example 62 example 63 example 69 example 70 baricitinib” are often aimed at one of these goals:
- determining whether baricitinib is disclosed in those specific examples (and thus whether a claim might cover baricitinib or baricitinib formulations),
- extracting the experimental conditions/results tied to baricitinib-like compounds,
- checking for chemical identity (is the example compound actually baricitinib?),
- assessing relevance for freedom-to-operate or patentability/invalidity arguments.
To answer any of those accurately, the exact example text (or the compound name/structure listed in each example) is needed.
If you share the example text, what can I do next?
If you paste:
- the compound name(s) or identifiers listed in Examples 62, 63, 69, and 70, and
- any explicit mention of baricitinib in those sections (or any tables listing biological data),
I can:
- confirm whether each example corresponds to baricitinib or not,
- summarize what each example is doing (synthesis vs assay vs formulation),
- point out where baricitinib is explicitly disclosed versus only implicitly related,
- highlight any assay readouts that matter for JAK inhibitor activity.
One thing to clarify
Do you want:
1) a summary of US8158616B2’s Examples 62/63/69/70, or
2) a direct confirmation of whether those examples disclose baricitinib, or
3) how those disclosures relate to baricitinib’s patent/litigation or generic/biologic freedom-to-operate?
Reply with the text from those examples (or a link and the exact example captions), and I’ll produce a targeted answer.